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Summary
We generated a CD8 T-cell receptor (TCR) transnuclear (TN) mouse
specific to the Ld-restricted immunodominant epitope of GRA6 from
Toxoplasma gondii as a source of cells to facilitate further investigation
into the CD8 T-cell-mediated response against this pathogen. The TN T
cells bound Ld-Gra6 tetramer and proliferated upon unspecific and pep-
tide-specific stimulation. The TCR beta sequence of the Gra6-specific TN
CD8 T cells is identical in its V- and J-region to the TCR-b harboured by
a hybridoma line generated in response to Gra6 peptide. Adoptively trans-
ferred Gra6 TN CD8 T cells proliferated upon Toxoplasma infection
in vivo and exhibited an activated phenotype similar to host CD8 T cells
specific to Gra6. The brain of Toxoplasma-infected mice carried Gra6 TN
cells already at day 8 post-infection. Both Gra6 TN mice as well as adop-
tively transferred Gra6 TN cells were able to significantly reduce the para-
site burden in the acute phase of Toxoplasma infection. Overall, the Gra6
TN mouse represents a functional tool to study the protective and
immunodominant specific CD8 T-cell response to Toxoplasma in both the
acute and the chronic phases of infection.
Keywords: antigens/peptides/epitopes; parasitic protozoan; T cells.
Introduction
Toxoplasma gondii is an intracellular protozoan parasite
infecting approximately 30% of the global human popula-
tion. Toxoplasma has a wide range of warm-blooded hosts
and in humans can cause disease in immunocompro-
mised individuals and congenital defects in fetuses. A
robust T-cell response mounted in immunocompetent
hosts controls parasite growth during both the acute and
chronic phases of infection through the production of
interferon-c (IFN-c).1 CD8 T cells have long been known
to elicit this critical protective function.2,3 Once infected,
the parasite persists within cysts in the brain and muscle
tissue of the host for its entire life. Crucially, patients
with T-cell deficiencies such as HIV-infected individuals
are highly susceptible to toxoplasmosis.4
To study the precise nature of the T-cell response to an
infection it is imperative to identify MHC ligands (or epi-
topes) recognized by the T-cell receptor (TCR). We have
previously identified epitopes derived from Toxoplasma
presented on either MHC Ld or Kb to CD8 T cells.5–7 We
further exploited somatic cell nuclear transfer to create
transnuclear (TN) TCR mice specific for two Ld-restricted
epitopes and one Kb-restricted epitope.8 All Toxoplasma
TN mice generated were shown to be functional in their
ability to respond to cognate peptide and the
Kb-restricted TN CD8 T cells were demonstrated to be
able to lower parasite load upon transfer to a Toxo-
plasma-infected animal.8
It had long been appreciated that BALB/c (H-2d) mice
compared with C57BL/6 (H-2b) mice are more resistant
to Toxoplasma infection and that this trait can be mapped
to the MHC I Ld locus9–15 and is critically dependent on
the parasite strain.16 The identification of the HF10
decapeptide derived from the Toxoplasma protein GRA6
and the finding that this response is immunodominant
explained these earlier observations.5 HF10 has an unu-
sual length of 10 amino acids rather than the classic nine
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amino acids commonly found in H-2Ld MHC I mole-
cules. Moreover, HF10 is polymorphic between different
Toxoplasma strains, with only type II parasites harbouring
the correct epitope.5 Interestingly, the C-terminal location
of the HF10 peptide within Gra6 determines its immuno-
genicity, rather than its affinity for the MHC I molecule
or the frequency of the T-cell precursors.17
Here, we report the TN CD8 T-cell mouse specific for
the Gra6 immunodominant epitope. We show that the
antigen-specific CD8 T cells from this mouse are respon-
sive to cognate peptide and functional. We further estab-
lished that Gra6-specific TN CD8 T cells are efficient at
reducing the parasite load in infected mice, and that
Gra6 TN mice themselves are more resistant to
Toxoplasma infective burden. Upon sequencing of the
TN TCR from the Gra6-specific mouse we found that
the b-chain is shared with the b-chain of the TCR
expressed by a traditionally generated hybridoma respon-
sive to Gra6 peptide.
Materials and methods
Mice
Transnuclear mice were generated as previously
described.8,18 Briefly, 2 weeks after intraperitoneal infec-
tion with T. gondii Pru tachyzoites, splenic CD8+ Gra6
tetramer+ cells were sorted by FACS and used as a source
of donor nuclei for somatic cell nuclear transfer (SCNT).
The mitotic spindle was removed from mouse oocytes
and replaced with donor nuclei. SCNT blastocysts were
used to derive embryonic stem cell lines. These embry-
onic stem cell lines were injected into wild-type
B6 9 BALB/c F1 blastocysts and implanted into pseudo-
pregnant females. The resulting chimeric pups were
mated to BALB/c females to establish the Gra6 TN line.
All animals used were backcrossed 10 generations onto
the BALB/c background. Parkes, Thy1.1 (BALB/c;
CD90.1+) and TN Gra6 mice on a Rag2-proficient BALB/
c (Rag2+/+ CD90.2+) background were housed and bred
in the animal facility of the Francis Crick Institute (Mill
Hill Laboratory, London, UK). All experiments were per-
formed in accordance with the Animals (Scientific Proce-
dures) Act 1986.
Reagents
Fluorescently labelled antibodies against CD3e, CD4,
CD90.2, CD62L, PD1 and KLRG1 antigens were pur-
chased from Biolegend (San Diego, CA). Fluorescently
labelled antibodies against CD8a (5H10) and CD69 were
purchased from Life Technologies (Carlsbad, CA). H-2Ld
monomers with HF10 (HPGSVNEFDF) or photo-cleava-
ble peptide [YPNVNI(Apn)NF] were obtained from the
NIH Tetramer Core Facility (Emory University, Atlanta,
GA) and were tetramerized and peptide-exchanged as
described previously.19 All peptides were synthesized by
Pepceuticals (Leicestershire, UK).
Parasites and cells
Toxoplasma Pru and CEP tachyzoites were grown in con-
fluent human foreskin fibroblasts maintained in Dul-
becco’s modified Eagle’s medium, 10% fetal calf serum.
Toxoplasma ME49 (type II) cysts were maintained in the
brains of Parkes mice.
TCR sequencing
Splenocytes from Gra6 TN mice were washed twice in
PBS and CD8 T cells were negatively selected by MACS
purification (Miltenyi Biotec, Bergisch Gladbach, Ger-
many). RNA was isolated and 50-rapid amplification of
cDNA ends (RACE) was performed according to the
manufacturer’s protocol (Invitrogen, Carlsbad, CA) using
reported primers.20
Genotyping of Gra6 TN mice
Primer trios were designed to detect in one PCR both
wild-type and rearranged Gra6-specific a- and b-chains:
a1: ACATGCGTCCTGACACCTGCTC, a2: ACTCACCGG
GGCTCTGGCTC, a3: AGCATGTGGGGTCAACGGCA,
b1: GCCCTGCATGCCCCACAGAG, b2: TCCGTTCCC
AAGCCAAAAGTGGT, b3: TCCCACCTGTATGGCCTC
TGCC.
In vitro proliferation assay
Negatively selected CD8 T cells (Miltenyi Biotec) were
isolated from spleens and lymph nodes of Gra6 TN mice
or wild-type (WT) BALB/c mice, labelled with 25 lM
CFSE (Life Technologies) for 5 min at room temperature
and stimulated in complete RPMI in 96-well flat-bottom
plates for 3 days in the conditions described below. For
anti-CD3/28 stimulation, plate-bound anti-CD3 (clone
17A2) and anti-CD28 (clone 37.51) at 5 lg/ml in the
presence of 10 ng/ml recombinant mouse interleukin-2
were employed. For splenocyte stimulation, splenocytes
from a WT BALB/c mouse loaded with Gra6 peptide
(10 lM) were plated together with CD8 T cells at a 3 : 1
ratio.
Adoptive transfer experiments
Lymph nodes from Gra6 TN donor mice were harvested
and the released cells were negatively selected for CD8 T
cells (Miltenyi Biotec). Recipient Thy1.1 (BALB/c) mice
received 106 Gra6+ CD8 T cells through intravenous
injection before infection. Mice were infected orally with
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five cysts of the ME49 Toxoplasma strain. Cells were har-
vested at the indicated time-points during the acute and
chronic phases of infection and were processed accord-
ingly.
Flow cytometric analysis of spleen, lymph node and
brain
Spleens and lymph nodes were dissociated and red
blood cells from spleens were removed using red blood
cell lysis buffer (Sigma, St Louis, MO). Cells were
counted and stained using a panel of antibodies indi-
cated in the experiment. Brain mononuclear cells were
isolated via Percoll gradient as described.21 Briefly, mice
were perfused with cold PBS and brains were isolated
and homogenized. Brain cell suspension was diluted to
30% with isotonic Percoll solution and layered on top
of 70% isotonic Percoll solution. Gradients were
spun for 30 min at 500 g, at 18°. The mononuclear cell
population was collected from the interphase of the
Percoll gradient, washed and resuspended for antibody
staining.
In vivo imaging/parasite load assessment
For direct infection. Gra6 TN mice or WT BALB/c mice
were infected intraperitoneally with 1 9 104 luciferase-
expressing Pru or CEP Toxoplasma tachyzoites.
For adoptive transfer experiments. Negatively selected
CD8 T cells (Miltenyi Biotec) were isolated from Gra6
TN mice (CD90.2) or WT BALB/c mice. A portion of
CD8 T cells from Gra6 TN mice was activated by over-
night co-culture with splenocytes loaded with 10 lM of
Gra6 peptide. A total of 1 9 106 cells were injected intra-
venously into congenic BALB/c (CD90.1) mice. Mice were
infected intraperitoneally with 1 9 104 luciferase-expres-
sing Toxoplasma Pru tachyzoites.22 An in vivo imaging
system (Xenogen, Alameda, CA) procedure for imaging
Toxoplasma-infected mice has been described in detail
previously.23 In short, mice were injected with 100 ll of
luciferin (3 mg) and immediately anaesthetized. Mice
were maintained for 10 min to allow for adequate dis-
semination of luciferin. Images were collected with 15-
second to 2-min integration times depending on the
intensity of the bioluminescent signal. Data acquisition
and analysis were performed using LIVINGIMAGE (Xenogen)
software with the IGORPRO image analysis package
(WaveMetrics, Seattle, WA).
Statistical analysis. The fluorescence intensity in the par-
asite load experiment was analysed using two-way analysis
of variance statistical analysis (GRAPHPAD PRISM version
6.0b for Mac OS X GraphPad Software, La Jolla, CA).
Results
Somatic cell nuclear transfer of Gra6+ CD8+ T cells
yields a functional Gra6-specific TN mouse
We sought to produce a CD8 TCR mouse specific to the
immunodominant epitope derived from the dense granule
protein GRA6 from T. gondii in order to further study the
nature of this response. Gra6-specific CD8 T cells were
sorted from Toxoplasma-infected spleens of BALB/
c 9 C57BL/6 F1 mice using Gra6-loaded H2-L
d tetramers,
and TN mice were generated as described previously.8 Chi-
meric mice were backcrossed to BALB/c mice to achieve
germline transmission and subsequently further back-
crossed for at least 10 generations. We compared the lym-
phocytes in thymus and spleen of Gra6 TN mice with those
of WT BALB/c mice (Fig. 1a). As expected, we observed an
increased percentage of single-positive CD8 thymocytes as
the prearranged Gra6-specific TCR is already determined
before the development of CD8 T cells. Similarly to the
thymus, in the spleen we also observed a reversed ratio of
CD4 and CD8 T cells between WT BALB/c and Gra6 TN
mice. An additional difference, a decreased percentage of
double-positive thymocytes and an increased percentage of
double-negative thymocytes (Fig. 1a) was previously
attributed to lymphocytes in TN mice as a sign of smooth
passage through negative and positive selection and earlier
expression of prearranged TCR genes.8
Gra6 TN mice exhibited about 60% of Gra6-specific
CD8 T cells in their splenic population as assessed by
binding to H2-Ld tetramer loaded with Gra6 peptide
(Fig. 1b). As both the Gra6 TN mice and BALB/c mice
showed < 2% tetramer-positive staining with the unre-
lated Rop7-Ld tetramer, we considered this to be back-
ground staining. BALB/c mice contain < 1% background
levels of Gra6-specific CD8 T cells (Fig. 1b). Upon
unspecific stimulation with anti-CD3 and anti-CD28,
Figure 1. Transnuclear (TN) Gra6 CD8 T cells are functional in response to peptide ex vivo. Cells were released from thymus and spleen of wild-
type (WT) BALB/c and Gra6 TN mice and stained for indicated surface markers. (a) Contour plots (left) and graphs (right) show ratios of CD8 to
CD4 T cells in thymus (top panel) and in the spleen (bottom panel). Line indicates mean with SD. Statistical significance was calculated with Stu-
dent’s t-test. , * p<0.05, ** p<0.01, *** p<0.001 (b) Splenocytes were stained to show Gra6-Ld tetramer binding on CD8 T cells. The graph on the
right shows percentage of the Gra6tet+ and Rop7tet+ (control tetramer) cells in Gra6 TN and BALB/c mice from three to five mice. Line indicates
mean with SD. (c) CD8 T cells from Gra6 TN mice and BALB/c control mice were stimulated with the indicated concentration of plate-bound a-
CD3/a-CD28 (upper panel) or Gra6 peptide-loaded splenocytes (lower panel). Shaded histograms represent non-stimulated control.
ª 2016 The Authors. Immunology Published by John Wiley & Sons Ltd., Immunology, 149, 270–279272
A. Sanecka et al.
66·318·2
3·88
BALB/c
BALB/c
BALB/c
BALB/c
BALB/c
BALB/c CD8 Tcells
Gra6 TN
Gra6 TN
Gra6 TN
Gra6 TN
Gra6tet+
non stimulated control
non stimulated control
Gra6 peptide
5 μg/ml α-CD3/α-CD28
1 μg/ml α-CD3/α-CD28
Rop7tet+
Gra6 TN
H2Ld Gra6 tet
Gated: live, CD3+CD8+
Gra6TN CD8 Tcells
 
59·2
80
60
40
0
3
2
1
0
20
80
60
40
0
20
80
70
60
40
50
9·5
26·2
46
13·4
33·658·2
63·2
Th
ym
oc
yt
es
liv
e:
%
 o
f C
D3
+
ce
lls
%
 o
f l
ive
 th
ym
oc
yt
es
0·253
Sp
le
no
cy
te
s
CD
3 
+
:
CFSECFSE
CD
4
CD4
35·7
9·49
DN
CD8 CD4 CD8
CD8SPCD4SP DN DP
%
 o
f l
ive
 C
D8
 T
 C
el
ls
CD
8
CD8
CD8 SP
DPCD4 SP
(a)
(b)
(c)
**
*
*
***
***
ª 2016 The Authors. Immunology Published by John Wiley & Sons Ltd., Immunology, 149, 270–279 273
Toxoplasma-specific transnuclear CD8 T cells
Gra6 TN cells proliferated as well as upon stimulation
with splenocytes loaded with Gra6 peptide (Fig. 1c). We
therefore concluded that we had generated a Gra6-specific
TN mouse model that is suitable to further investigate
this specific immunodominant CD8 T-cell response to
Toxoplasma.
Identification of the TCR sequence in CD8 T cells
specific for the Gra6 epitope
To be able to track the generated Gra6-specific TN mice
by genotyping, we identified the sequence of the genomic
rearranged TCR specific for Gra6 by RACE–PCR. The
Gra6 TN TCR
Gra6 TN TCR
J-Region C-RegionV-Region N
Gra6 TN TCR
T-cell line
TCR TCR
HPGSVNEFDF
HPGSVNEFDF
Gra6 TN:
Gra6 HB:
Peptide sequence
recognized (HF10)V J V JD
Gra6 TN 12D-2 57 1 1 2-1
6-7 52 1 1 2-1Gra6 HB
J-Region C-RegionV-Region N
Gra6 TN TCR
(a)
(b)
α β
α
β
α
β
Figure 2. T-cell receptor (TCR) sequence of Gra6 transnuclear (TN) T cells and transgenic (TG) hybridomas resemble each other. (a) Nucleic
acid sequences of the a and b chain of the Gra6 TN TCR and amino acid sequence of CDR3 regions of a and b chain of the Gra6 TN TCR. (b)
The table represents a comparison of the gene and allele usage by the a (V and J) and b (V, D and J) chains of the TCRs and a comparison of
the amino acid sequence of CDR3 region of b chains of the TCRs of the TN CD8 T cells (Gra6 TN) and a CD8 T-cell hybridoma (Gra6 HB)
specific to Gra6 peptide (HF10).
Figure 3. In vivo responsiveness of Gra6 transnuclear (TN) CD8 T cells to Toxoplasma infection. (a) CD8 T cells from spleens of Gra6 TN mice
and wild-type (WT) BALB/c mice were stained with activation markers. Histograms shown are representative of at least three mice. Cells were
gated as live, CD3+ CD8+ Gra6tet+ (black line) for Gra6 TN mice and CD3+ CD8+ (grey-shaded histogram) for BALB/c mice. (b, c) Donor CD8
T cells were isolated from spleens and mesenteric lymph nodes (mLN) of Gra6 TN mice using a negative CD8 T-cell selection kit; 1 9 106 Gra6
TN CD8 T cells were adoptively transferred to congenic mice that were infected orally with five brain cysts of Toxoplasma ME49 (type II). (b)
Adoptively transferred Gra6 TN CD8 T cells proliferate in vivo upon Toxoplasma type II infection. Graphs show CFSE dilution of labelled and
transferred Gra6 TN cells in the mLN and spleen 6 and 7 days post-infection with Toxoplasma. (c) Gra6 TN cells are detected in the brain at
8 days post-infection with Toxoplasma. Dot plots show the proportion of donor and host CD8 T cells 8, 14 and 21 days post infection in the
brain. (d) Phenotype of Gra6-specific host, adoptively transferred Gra6 TN cells or total host CD8 T-cell population at day 8 post-infection in
the mLN and brain of Toxoplasma-infected BALB/c recipient mice. One representative plot of three mice is shown per time-point. In the leftmost
contour plots cells are gated as live, CD8+. The dot plot on the left indicates the gating strategy for the overlaid histograms:
CD8+ CD90.2+ Gra6tet+ (black line), CD8+ CD90.2 Gra6tet (grey-shaded area), CD8+ CD90.2 Gra6tet+ (red line).
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resulting sequence of the a- and b-chain of the TCR of
the TN mice is depicted in Fig. 2(a). The established
genotyping protocol can be found in Materials and meth-
ods.
Next, we compared the TCR sequence of the Gra6-spe-
cific TN mice with the sequence of the TCR of an exist-
ing b-galactosidase-inducible reporter CD8 T-cell
hybridoma generated by successive in vitro re-stimulations
of splenocytes from Toxoplasma-immunized mice with
Toxoplasma-infected macrophages5 (Fig. 2b). Different V
and J genes are recombined to build the a-chain of
the TCR for these two T-cell clones. Interestingly, for
TCR b-chain, the same V, D and J genes were
recombined. The sequence of the b-chain of the TCR is
almost identical between the two T-cell clones with the
exception of two amino acids in the CDR3 region
(Fig. 2b).
Gra6-specific TN CD8 cells are responsive to
T. gondii infection and exhibit an activated phenotype
Gra6 TN CD8 T cells from the spleen exhibit a naive
phenotype as shown by low expressions of CD69, PD1
and KLRG1 markers and high expression of CD62L
(Fig. 3a). Wild-type CD8 T cells of BALB/c mice show
the same phenotype (Fig. 3a). Active proliferation of
adoptively transferred Gra6-specific TN CD8 T cells was
observed in vivo between days 6 and 7 post-infection in
the mesenteric lymph nodes (mLN) and the spleen of a
congenic BALB/c host infected with Toxoplasma (Fig. 3b).
When assaying on what day Gra6-specific CD8 T cells
arrive in detectable numbers in the brain of a Toxo-
plasma-infected BALB/c mouse, we were surprised to
encounter host CD8 T cells as well as adoptively trans-
ferred Gra6 TN cells as early as 8 days post-oral infection
(Fig. 3c). At day 14, > 80% of CD8 T cells in the brain
were donor Gra6 TN CD8 T cells. In the chronic phase
of infection (day 21) still most of the CD8 T cells in the
brain were from the donor. In the mLN during the acute
phase of infection we observed an activated phenotype of
donor cells as shown by expression of activation markers:
CD62Llo, CD69hi, PD1hi and KLRG1hi (Fig. 3d). Host
Gra6-specific CD8 T cells were activated in a similar way
to donor cells; however, only a small fraction of them
was positive for KLRG1. The majority of the host CD8 T
cells in mLN at day 8 post-infection were still in a naive
state. In the brain the phenotype of donor cells was also
activated and similar to the host population. KLRG1
expression on the Gra6 TN cells in the brain was much
higher than on the majority of host cells mirroring the
situation in mLN (Fig. 3d). During the course of infec-
tion the phenotype of the donor cells did not change
drastically. At day 14 and day 21 post-infection in mLN
and in the brain Gra6 TN CD8 T cells exhibited a similar
profile to what we observed during the acute phase of
infection (see Supplementary material, Fig. S1).
Gra6-specific TN CD8 cells confer protection against
T. gondii challenge
We next aimed to characterize the protective capabilities
of the Gra6 TN cells in vivo, as well as the response that
these mice would show towards direct challenge with
Toxoplasma. For this we transferred either 1 9 106 WT
BALB/c CD8 T cells compared with naive or activated
Gra6 TN CD8 T cells into BALB/c recipients and chal-
lenged the mice with 1 9 104 Toxoplasma Pru intraperi-
toneally. Gra6 TN CD8 T cells efficiently controlled the
parasite load from day 7 post-infection onwards (Fig. 4a).
Previously peptide-activated Gra6 TN T cells were even
more effective at reducing parasite load at 7 days post-
infection (Fig. 4a). Gra6 TN mice directly infected with
1 9 104 Toxoplasma Pru exhibited a much-increased con-
trol of parasite load compared with WT BALB/c infected
mice (Fig. 4b). Already 5 days post infection, the Toxo-
plasma load in the peritoneum was on average 15 orders
of magnitude lower than in WT animals (Fig. 4b). Gra6
TN mice directly infected with Toxoplasma CEP, a type
III strain that does not express the Gra6 epitope HF10,
were not able to control parasite burden better than WT
mice (Fig. 4c).
Discussion
We generated Ld-restricted TN TCR mice specific to the
immunodominant epitope HF10 from the dense granule
protein Gra6 in order to obtain a source of these CD8 T
cells. As previously described,8 the nucleus from a Toxo-
plasma-specific T-cell is harvested and transferred into an
enucleated mouse oocyte that can then develop into a
Figure 4. Gra6 transnuclear (TN) CD8 T cells lower the parasite load in in vivo Toxoplasma challenge. (a) 1 9 106 Gra6 TN CD8 T cells (naive
or activated with Gra6 peptide) or control wild-type (WT) BALB/c CD8 T cells were adoptively transferred to BALB/c mice. Mice were infected
intraperitoneally with 1 9 104 Pru (type II) Toxoplasma tachyzoites expressing luciferase. (b, c) Gra6 TN mice and BALB/c mice were directly
infected intraperitoneally with 1 9 104 (b) Pru (type II) or (c) CEP (type III) Toxoplasma tachyzoites expressing luciferase. At day 3, 5, 7 and 10
post infection parasite load was estimated by luminescence using an in vivo imaging system. Each symbol represents one mouse; small horizontal
lines indicate the mean, the bottom and top of the box are the first and third quartiles. Data are representative for at least two independent
experiments with three to five mice (a, b) or one experiment with three mice (c). Statistical significance was calculated using two-way analysis of
variance.
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blastocyst and be used to generate embryonic stem cells.
In this process, the antigen-specific T cells are directly
isolated from an infected mouse, which circumvents the
necessity of lengthy in vitro culture thereby eliminating
the skewing of the T-cell repertoire to adapt to these arti-
ficial conditions. The derived embryonic stem cells were
then used to generate TN mice that harbour their TCR in
the endogenous locus under their natural promoters
without any genetic trace. TN mice can be generated with
relative ease and are now available for several model and
pathogen antigens. Currently the repertoire encompasses
B-cell TN mice and CD8 T-cell TN mice.8,24–27
We established that the TCR-b chain of our TN mice
and a previously described Gra6-specific hybridoma were
almost identical in the CDR3 region responsible for the
interaction with the peptide. No discernable homology
was found in the TCR-a chain of the TN mouse versus
the Gra6-specific hybridoma. It is possible that to be able
to recognize HF10, an unusually longer peptide compared
with the typical nonamers presented by Ld, the CDR3 of
the b-chain must be ‘fixed’ or at least display limited
sequence variability. It would be interesting to sequence
TCRs of other naturally occurring Gra6-specific clones to
test this theory.
Host Toxoplasma-specific CD8 T cells exhibited a
broadly similar activation phenotype as donor Gra6 TN T
cells in both the mLN and the brain. Specifically, both acti-
vated T cells demonstrate low CD62L and high CD69
levels. Most CD8 T cells found in the brain can be assumed
to be Toxoplasma-specific, as uninfected brains do not con-
tain CD8 T cells. It is noteworthy that the host Gra6-speci-
fic CD8 population in the mLN as well as the polyclonal
Toxoplasma-specific CD8 population in the brain displayed
KLRG1low phenotypes. In contrast, donor Gra6 TN CD8 T
cells exhibited KLRG1high expression at both sites. The pre-
sumably polyclonal response of the host CD8 T cells in the
brain to varying Toxoplasma epitopes and the polyclonal
Gra6-specific response in the mLN versus the monoclonal
response of Gra6 TN CD8 T cells may be responsible for
this observed difference. In viral infections, it has been
shown that both KLRG1low and KLRG1high perform equally
well as effector cells.28 In terms of memory potential, high
KLRG1 expression on all Gra6 TN CD8 T cells in the mLN
and brain suggests that this population is destined for ter-
minal short-lived effector cells.29
We have previously shown that the Toxoplasma load in
the acute phase of infection can be lowered by adoptive
transfer of naive CD8 TN T cells specific for one epitope
in the susceptible C57BL/6 mouse model.8 Unsurpris-
ingly, in this model we did not observe a significant
increase in survival when the mice were challenged with a
lethal dose of Toxoplasma. Most likely, the transferred T-
cell clone is not the immunodominant one, or alterna-
tively a cocktail of CD8 T-cell specificities would be
needed. In the resistant BALB/c model, we have tested
the ability of three different Rop7-specific TN T cells to
lower the Toxoplasma load after adoptive transfer and did
not observe this capability (EMF and HP, unpublished
observations). Again, this is not surprising, as the CD8 T
cells specific for Rop7 only arise in the chronic phase of
infection and can therefore not represent the immun-
odominant acute-phase response.
In contrast, the peptide HF10 from Gra6 has been shown
to be the mediator of the immunodominant CD8 T-cell
response in BALB/c mice.5 BMDCs pulsed with HF10 pep-
tide elicited a protective immune response in H-2d B10.D2
mice. Moreover during the acute stage in BALB/c mice,
parasites expressing an HF10-containing Gra6 were cleared
faster than parasites expressing a polymorphic version of
Gra6, devoid of HF10.17 It was therefore plausible to
assume that CD8 T cells specific for Gra6 would be able to
significantly reduce parasite burden. Indeed, when we
transferred Gra6 TN T cells into BALB/c mice and subse-
quently challenged them with Toxoplasma, we could
observe that naive Gra6 TN cells could reduce the parasite
burden. This protective effect is completely ablated when
the mice are infected with a Toxoplasma strain that does
not harbour the Gra6 epitope. When employing in vitro
peptide-activated Gra6 TN T cells, we observed an even
more efficient reduction in parasite burden.
In this study, we have generated a fully functional TN
CD8 T-cell mouse specific for the immunodominant Tox-
oplasma epitope Gra6 on a BALB/c background. We con-
firmed that Gra6-specific TN CD8 T cells are able to
productively lower parasite burden during the acute phase
of Toxoplasma infection in a BALB/c mouse. Importantly,
the Gra6 TN mice as well as our previously generated
Rop7-specific ones are on a BALB/c background, a mouse
strain that readily progresses into the chronic phase of
Toxoplasma infection, in striking contrast to C57BL/6
models that generally succumb during the acute phase.
This mouse model can provide a large number of non-
activated CD8 T cells specific for the Toxoplasma immun-
odominant epitope, with one affinity for the MHC I
loaded with the Gra6 peptide. Properties of the acute
phase of infection CD8 T cells can therefore be studied
and further inform on determinants that are important
for vaccine development. Additional studies centred
around the properties of CD8 T cells in the clinically
important chronic phase of Toxoplasma infection will be
facilitated by employing both of these BALB/c models of
TN CD8 T-cell mice.
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